1α,25-dihydroxy-19-nor-vitamin D3, a novel vitamin D-related compound with potential therapeutic activity

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Tetrahedron Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0040-4039(00)98795-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis of some side-chain homologues of 1 alpha,25-dihydroxyvitamin D3 and investigation of their biological activities.

  1986cited by this paper
• ELECTROPHILIC ADDITION OF OSMIUM TETROXIDE TO 25-HYDROXYCHOLECALIFEROL AND ITS 3,5-CYCLO DERIVATIVE

  1983cited by this paper
• Direct C(1) hydroxylation of vitamin D3 and related compounds

  1980cited by this paper

• The inhibition of growth and metastasis of human pancreatic ductaladenocarcinoma by MART-10

  2023cites this paper
• Design, synthesis, and properties of des-D-ring interphenylene derivatives of 1α,25-Dihydroxyvitamin D3.

  2022cites this paper
• Synthesis of C2-Alkoxy-Substituted 19-Nor Vitamin D3 Derivatives: Stereoselectivity and Biological Activity

  2022cites this paper
• First Experimental Quantitative Charge Density Studies of Advanced Intermediate of Vitamin D Analogues

  2022cites this paper
• Strategies for the Design of Vitamin D Receptor Ligands

  2021cites this paper
• Vitamin D and its analogs

  2020cites this paper
• Strategies for the Synthesis of 19-nor-Vitamin D Analogs

  2020cites this paper
• Structural Basis for Ligand Activity in Vitamin D Receptor

  2018cites this paper
• Enzymatic Desymmetrization of 19‐ nor ‐Vitamin D 3 A‐Ring Synthon Precursor: Synthesis, Structure Elucidation, and Biological Activity of 1α,25‐Dihydroxy‐3‐ epi ‐19‐ nor ‐vitamin D 3 and 1β,25‐Dihydroxy‐19‐ nor ‐vitamin D 3

  2018cites this paper
• Synthesis of paricalcitol: A novel strategy combining chemical and microbial transformations

  2017cites this paper
• D-seco-Vitamin D analogs having reversed configurations at C-13 and C-14: Synthesis, docking studies and biological evaluation.

  2017cites this paper
• 1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Metastasis After VEGF-A Stimulation.

  2017cites this paper
• A‐Ring‐Modified 2‐Hydroxyethylidene Previtamin D3 Analogues: Synthesis and Biological Evaluation

  2017cites this paper
• A-Ring Synthons of 19-Nor Type Vitamin D Derivatives.

  2017cites this paper
• Synthesis of 19-norcalcitriol analogs with alkylidene moieties at C-2 based on succinic acid and l-methionine.

  2017cites this paper
• A new approach to 19-nor-A-ring phosphine oxide for the convergent synthesis of 19-nor-calcitriol.

  2017cites this paper
• Seco-B-Ring Steroidal Dienynes with Aromatic D Ring: Design, Synthesis and Biological Evaluation

  2017cites this paper
• Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D3 analogues.

  2017cites this paper
• A new metabolite of Paricalcitol: stereoselective synthesis of (22Z)-isomer of 1α,25-dihydroxy-19-norvitamin D2

  2016cites this paper
• Structural analysis and biological activities of BXL0124, a gemini analog of vitamin D.

  2016cites this paper
• MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.

  2016cites this paper
• The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential

  2016cites this paper
• Synthesis of Diastereomers of 1,3-cis-25-Dihydroxy-19-norvitamin D3.

  2016cites this paper
• Metabolism and Action of 25-Hydroxy-19-nor-Vitamin D₃ in Human Prostate Cells.

  2016cites this paper
• 19-Norvitamin D analogs for breast cancer therapy.

  2015cites this paper
• MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential.

  2015cites this paper
• Synthesis and biological activity of two C-7 methyl analogues of vitamin D.

  2015cites this paper
• The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells.

  2014cites this paper
• Structural development of p-carborane-based potent non-secosteroidal vitamin D analogs.

  2014cites this paper
• MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.

  2014cites this paper
• Synthesis of 19‐Nor‐Vitamin D A‐Ring Synthons via Ring‐Closing Olefin Metathesis

  2014cites this paper
• Advances on Synthesis of 1α,25-Dihydroxyvitamin D3 and Related Analogues

  2014influential citation
• Synthesis of 2‐Ethyl‐19‐nor Analogs of 1α,25‐Dihydroxyvitamin D3

  2013cites this paper
• Synthesis of novel 19-norvitamin D3 analogs with unnatural triene system.

  2013cites this paper
• Synthesis and crystallographic study of 1,25-dihydroxyergocalciferol analogs.

  2013cites this paper
• Ring-A-seco analogs of α ,25-dihydroxy-19-norvitamin D 3

  2013cites this paper
• Recent Developments of 19‐Nor‐1,25‐dihydroxyvitamin D3 Analogues

  2013cites this paper
• Vitamin D analogs.

  2012cites this paper
• The difference between 14-epi-previtamin D3 and 14-epi-19-norprevitamin D3: their synthesis and binding affinity for human VDR.

  2012cites this paper
• A general approach to the synthesis of enantiopure 19-nor-vitamin D3 and its C-2 phosphate analogs prepared from cyclohexadienyl sulfone.

  2012cites this paper
• Vitamin D Analogs and Their Clinical Uses

  2012cites this paper
• A-ring analogs of 1,25-dihydroxyvitamin D(3).

  2012cites this paper
• Potent 19-norvitamin D analogs for prostate and liver cancer therapy.

  2012cites this paper
• MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D3 in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells

  2012cites this paper
• 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.

  2011cites this paper
• Chapter 74 – Alterations in 1,25-Dihydroxyvitamin D3 Structure that Produce Profound Changes in in Vivo Activity

  2011cites this paper
• Analogs of calcitriol

  2011cites this paper
• Novel Vitamin D Analogs for Prostate Cancer Therapy

  2011cites this paper
• Design and synthesis of active vitamin D analogs.

  2010cites this paper
• Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids.

  2010cites this paper
• STUDIES ON THE SYNTHESIS AND METABOLISM OF 14-epi-2α-(3-HYDROXYPROPYL)-19-NORVITAMIN D3 AND ITS 2β-ISOMER

  2010cites this paper
• Analysis of Vitamins D, Their Metabolites and Analogues

  2010cites this paper
• Ligand-dependent conformation change reflects steric structure and interactions of a vitamin D receptor/ligand complex: a fragment molecular orbital study.

  2010cites this paper
• Metabolism and Catabolism of Vitamin D, Its Metabolites, and Clinically Relevant Analogs

  2010cites this paper
• An o-aminoanilide analogue of 1α,25-dihydroxyvitamin D(3) functions as a strong vitamin D receptor antagonist.

  2010cites this paper
• [2,3] Wittig Rearrangement of β’-Hydroxyethyl Bis-Allylic Ethers: Highly Regiospecific Entry to Singly Dehydroxylated 19-Nor-1(or 3),25-dihydroxy-vitamin D3

  2010cites this paper
• Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity.

  2009cites this paper
• Novel synthesis of 1α,25-dihydroxy-19-norvitamin D from 25-hydroxyvitamin D.

  2009cites this paper
• Synthesis of 22-oxaspiro[4.5]decane CD-ring modified analogs of 1α,25-dihydroxyvitamin D3

  2009cites this paper
• Evaluation of 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 as a Therapeutic Agent for Androgen-dependent Prostate Cancer

  2009cites this paper
• Synthesis and structure-activity relationships of 16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes.

  2008cites this paper
• Structural refinement of seco-steroidal skeleton and the biological activity through nuclear receptors.

  2008cites this paper
• Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist

  2008cites this paper
• 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.

  2008cites this paper
• Synthesis of 14-epi-19-nor-22-oxa-1α,25-dihydroxyvitamin D3

  2008cites this paper
• Vitamin D and Analogues

  2008cites this paper
• Is osmylation always preferring the richest double bond

  2008cites this paper
• New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro.

  2007cites this paper
• Synthesis of γ- and δ-lactones from 1α-hydroxy-5,6-trans-vitamin D3 by ring-closing metathesis route and their reduction with metal hydrides

  2007cites this paper
• Synthesis of an optically active intermediate for A-ring of 19-nor-1α,25-dihydroxyvitamin D3

  2007cites this paper
• Procédé et intermédiaire pour la fabrication du dérivé 1-hydroxy-19-norcyclovitamine d

  2007cites this paper
• The development of CD-ring modified analogs of 1alpha,25-dihydroxyvitamin D.

  2007cites this paper
• Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position.

  2007cites this paper
• Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.

  2006cites this paper
• Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.

  2006cites this paper
• Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.

  2006cites this paper
• Application of ring-closing metathesis to the synthesis of 19-functionalized derivatives of 1alpha-hydroxyvitamin D3.

  2006cites this paper
• Synthesis of spiro[4.5]decane CF-ring analogues of 1 alpha,25-dihydroxyvitamin D3.

  2006cites this paper
• Nephrology Dialysis Transplantation New vitamin D analogues

  2005cites this paper
• Novel A-ring analogs of the hormone 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation.

  2005cites this paper
• The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.

  2005cites this paper
• A-ring hydroxymethyl 19-nor analogs of the natural hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.

  2005cites this paper
• New derivatives of 1α, 25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity

  2005cites this paper
• CHAPTER 87 – 2-Carbon-Modified Analogs of 19-Nor-1α,25-Dihydroxyvitamin D3

  2005cites this paper
• CHAPTER 81 – Analog Metabolism

  2005cites this paper
• Synthesis of 2‐Methyl and Ethyl‐Substituted 19‐nor‐1α,25‐Dihydroxyvitamin D3 Analogues via the Cyclovitamin Strategy

  2005cites this paper
• Chemopreventive Efficacy of Natural Vitamin D and Synthetic Analogs

  2004cites this paper
• Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1α,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues

  2004cites this paper
• Therapeutic potential of the 2-alkyl and 2-alkylidene-19-nor-(20S)-modified analogs of 1alpha,25-dihydroxyvitamin D3.

  2004cites this paper
• Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1 alpha,25-dihydroxyvitamin D analogs.

  2003cites this paper
• Previtamin D3 with a trans-Fused Decalin CD-ring Has Pronounced Genomic Activity*

  2003cites this paper
• Synthesis of C-19-functionalized 1alpha-hydroxyvitamin D(2) analogues via ring-closing metathesis.

  2003cites this paper
• Cancer chemoprevention using natural vitamin D and synthetic analogs.

  2003cites this paper
• Novel synthesis of 2-substituted 19-norvitamin D A-ring phosphine oxide from D-glucose as a building block.

  2003cites this paper
• 2,2-Disubstituted analogues of the natural hormone 1α,25-dihydroxyvitamin D3: Chemistry and biology

  2002cites this paper
• Design and efficient synthesis of new stable 1alpha,25-dihydroxy-19-norvitamin D3 analogues containing amide bond.

  2002cites this paper
• Vitamin D3: synthesis of seco C-9,11,21-trisnor-17-methyl-1α, 25-dihydroxyvitamin D3 analogues

  2002cites this paper
• New highly calcemic 1α,25-dihydroxy-19-norvitamin D3 compounds with modified side chain: 26,27-dihomo- and 26,27-dimethylene analogs in 20S-series

  2002cites this paper
• Vitamin D and Analogs

  2002cites this paper
• Novel synthetic approach to 19-nor-1alpha,25-dihydroxyvitamin D(3) and its derivatives by Suzuki-Miyaura coupling in solution and on solid support.

  2001cites this paper